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It is the function of medicine to assist us to die
young — as late as possible.
Greek adage
A casual viewing by any health care prac-
titioner of the items on the shelves of
almost every pharmacy or certainly of
every health store, will speedily assure the
visitor that there is a vast world of herbal,
homeopathic, naturopathic, nutritional
and other less readily classifiable supple-
ments available to meet the needs of, and
to interest and engage — if not confuse
and confound – every citizen of our coun-
try.
Fortunately, in our task of being informed
of allopathic medications, we are assisted
by the availability of highly informative
official documentation such as the pack-
age inserts which are authorised by the
Medicines Control Council, and publica-
tions such as the South African Medicines
Formulary.
However, when it comes to the vast array
of complementary medications, the ready
availability of any, let alone enlightening,
information is seriously deficient. The
Medicines Regulatory Authorities in many
countries are busy devising methods to
counter this situation, which may be very
helpful in at least contriving to assure the
contents and quality of complementary
medications.
This preamble sets the scene for an
attempt at an evaluation of the antioxi-
dants as constituting real medicines. If
any nutritional-type supplements have
been subject to widespread orthodox
examination, then several well-known
antioxidants must qualify. This huge
interest derives from the widely held belief
that the antioxidants should have a salu-
tary role to play in the prevention, retar-
dation and even reversal of many of the
pathologies that beset the lives of humans
and other animals.
OXYGEN FOR LIFE AND
DISASTER
Our reliance on oxygen for the mainte-
nance of aerobic life on our Blue Planet is
a taken. The total respiratory process is
one of making oxygen available to meet
the energy needs of every cell in our bod-
ies. We must be cognisant of the fact that
oxidation plays a vital role not only in the
respiratory chain but also in anti-infective
activity, cell division and maturation and
apoptosis, immunological processes, vaso-
activity, etc.These are essential ‘survival
activities’ of living tissue.
It seems that every cell in our bodies is
bombarded by thousands of oxidative
insults every minute of every day.
Damage as a result of excessive or uncon-
trolled oxidation is widely documented,
nowhere more extensively than in the
emergence of metabolic and cardiovascu-
lar disorders1 such as atherosclerosis,
myocardial infarction, stroke, endothelial
dysfunction, peripheral vascular insuffi-
ciency, diabetes mellitus, dementias,
Parkinson’s disease, and retinal macular
degeneration. The serious toxicity of oxy-
gen itself when administered to neonates
and especially to premature infants is well
known.2
While endogenous metabolic pathways
utilise oxidative processes largely for our
benefit, various pathological processes
such as autoimmune disorders set up
oxidative activities against our own tis-
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Antioxidants are widely recommended despite
the lack of unequivocal clinical trials showing
b e n e f i t s .
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sues. Furthermore, exogenous
sources of oxidative stress may shift
the balance from benefit to disas-
ter. Smoking burdens every cell
with a barrage of oxidants (and
other poisons), as does atmospher-
ic pollution from vehicles such as
cars and aircraft — jet aircraft in
particular; in short, fires (combus-
tion) of every description add to
the oxidative load in our environ-
ment. A wide variety of medica-
tions, radiation such as X-rays,
strenuous physical exercise, all
forms of inflammation, excess alco-
hol, trauma of every type etc., add
to our oxidative load.
Oxidative stress is obviously coun-
tered by myriads of endogenous
processes; if this were not so, sur-
vival would not be possible. Our
bodies are provided with a host of
enzyme systems and chemicals that
have the ability to ‘neutralise’
oxidative stressors (Fig. 1). But it
must be noted that our defensive
capacity relies very extensively on
our dietary intake of an abundant
supply of protective chemicals that
are distributed about our organs in
amounts appropriate to the
demands made upon them.
OXIDATIVE ATTACK
Oxidative attack is held to be
responsible for a host of disorders.
Table I lists some conditions where
oxidative damage is regarded as
prominent.
The diabetic state is characterised
by a progressive burden of glyca-
tion — a process where non-utilis-
able glucose encumbers (‘glucosi-
lates’) an enormous variety of cel-
lular and subcellular structures and
chemicals (the HbA1C level which
we use to gauge glycaemic control
is a reflection of this glycation
process). Glycated structures are
particularly prone to oxidation, and
thus the term ‘glycoxidation’ has
come into use to describe the dev-
astating dual glycation-oxidation
• Cataracts • Raynaud’s disease
• Retinal/macular degeneration • Diabetic retinopathy
• Endothelial dysfunction • Diabetic neuropathy
• Atherosclerosis • Sunburn
• Hypertension • Solar keratoses
• Cardiac failure • Cancers
• Plaque rupture • Amyotrophic lateral sclerosis
• Myocardial infarction • Parkinson’s disease
• Coronary reperfusion injury • Alzheimer’s disease
• Coronary stent restenosis • Ageing































Fig. 1. Repercussions of controlled and uncontrolled ‘combustion’.
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processes that damage the bodies
of diabetics in particular. This sit-
uation helps to explain the vastly
increased risk of diabetics for car-
diovascular and other disorders.
ACTIVE RADICALS 
When oxidation occurs, electrical
charges in the form of electrons are
passed onto susceptible acceptors,
which then become what are
termed ‘active radicals’. If these
active radicals are not promptly
deactivated, a cascade of electron
transfer can follow that has the
potential ability to damage the
components of every cell, and set
in motion inflammatory processes
that may become self-propagating.
DNA, RNA, enzymes, mitochon-
dria, cellular and subcellular mem-
branes, lipids and lipoproteins,
proteins, and the active elements of
rapidly dividing cells are particu-
larly at risk.
Table II lists some of the many
active oxidants that have been
described and characterised.
Likewise, many of the endogenous
quenchers of these oxidants have
been discovered and characterised.
Endogenous antioxidants may be
enzymatic or non-enzymatic.
Some of the many endogenous
substances involved in active radi-
cal quenching are listed in Table
III.
However, as suggested above, our
bodies rely on the regular ingestion
of a vast array of active-radical
quenchers to support their
defences against active radical
attack.
DIETARY ANTIOXIDANTS
Antioxidant vitamins such as vita-
min E, vitamin C, β-carotene, and
perhaps lipoic acid, are likely to be
well known to most health care
practitioners.
Table IV lists some examples of
antioxidants found in foodstuffs.
It should be noted that plant foods
are our greatest source of these
potentially protective substances.
While the chief vitamins which
have antioxidant capacity are readi-
ly recognised, what is much less
well known is the fact that vitamin
E is a family of 8 vitamins: 4 toco-
pherols (α, β, γ, δ) and 4
tocotrienols (α, β, γ, δ).Yet the
almost invariable form used in
clinical studies and also found in
the vast proportion of supple-
ments, is the racemate (dl form) of
α-tocopherol. However, in nature
the d-form predominates, but then
also it is never found on its own: it
is always in association with its nat-
ural congeners, β,γ and δ-toco-
pherol, and the α, β, γ and δ-
tocotrienols. Furthermore, the
USA diet — chosen because it is
well documented in this regard —
contains more γ-tocopherol than
any other form of  vitamin E.3 So
why is α-tocopherol the almost








• Nitric oxide radical




Table II. Examples of
well-characterised 
oxidants and active 
radicals




• Glutathione and its peroxidase, and its reductase
• Plasma protein thiols which provide sulphydryl [-SH] groups
• Melatonin, oestrogens, DHEA, creatine, taurine, etc.
Table III. Examples of endogenous antioxidants
Flavonoids — over 4 000 from edible plant foods have been charac-
terised
Carotenoids — α, β, γ, δ; lycopene, lutein; more than 600 carotenoids
are known
Proanthocyanidins and polyphenols — blue-red/violet pigments in
grapes, berries, etc; epicatechins, catechins — tea
Phytosterols — mango, soybeans, butternut, yams
Isoflavones — soy and many pulses, yams
Thiols — garlic, cabbage
Allylic sulfides — garlic, broccoli
Tocotrienols and tocopherols (vit-E) — α, β, γ, δ; grains, seed oils





Selenium — critical co-factor for many thio-peroxidases
Table IV. Examples of some antioxidants found in
dietary sources
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ies and for supplements?  No sub-
stantial argument is found in
favour of this choice.The
carotenoid family is some 600
members strong, so we must ques-
tion why β-carotene is selected for
clinical studies as the ‘representa-
tive’ of this large family.
A large number of allopathic med-
ications are also known to have
marked in vitro antioxidant proper-
ties; these include allopurinol,
aspirin, carvedilol (remarkably
potent), metformin, paracetamol
(in conventional dosage), various
steroids such as oestrogens and
dehydroepiandrosterone, probucol,
some statins, some ACE-inhibitors,
some fibrates, N-acetylcysteine,
colchicine, verapamil, and more.
Whether this antioxidant activity of




Antioxidant supplements are being
extensively promoted for their
health benefits, but do these sup-
plements do any good?  The main
thrust of this article is to examine
this question.
A very large number of clinical
studies have been conducted — at
massive expense — to investigate
the possible role of various antioxi-
dants in the prevention and con-
tainment of chiefly cardiovascular
diseases, but also other degenera-
tive disorders and cancers.
Essentially this approach derives
from epidemiological studies,
which have shown that populations
with good bodily levels of various
antioxidants have less index dis-
ease. And the point of departure
in such studies is that the antioxi-
dants are regarded as pharma-
cotherapeutic agents, in the same
way as we might consider β-block-
ers, aspirin or warfarin to be phar-
macotherapeutic agents. Thus, the
best clinical trials make use of one
or more individual antioxidants
and administer them — usually in
doses that are decidedly higher
than might be found in a good
dietary regimen, for periods that
vary from months to years, and
compare the effects with those of a
placebo, in a double-blind con-
trolled manner.
It is recognised that cardiovascular
diseases are major morbidity and
mortality factor s. Efforts at reduc-
ing such diseases are universally
encouraged, and oxidative mischief
is regarded as a universal compo-
nent in most forms of cardiac and
vascular disorders. Thus, in seek-
ing to beneficially modify cardio-
vascular disease, several antioxi-
dants have been put to the test.
Vitamin E (almost invariably as α-
tocopherol), vitamin A, β-carotene
and vitamin C have received most
attention. In vitro studies show
these vitamins to possess major
antioxidant capacity, and large
studies have examined the effects
of chiefly these antioxidants alone
or in various combinations, for
their possible ability to modify an
array of cardiovascular and other
disorders.The outcomes of these
studies (and some of them are
huge in terms of subject numbers,
their time frames and cost) are so
disparate that they must urge us to
question the advisability of further
similar antioxidant studies!  
While some benefits have been
demonstrated in several of the
individual studies, nothing consis-
tent across the studies emerges.4
Indeed, it is a sad situation when
studies probing individual antioxi-
dants for possible benefits, actually
produce results that show an
increase in morbidity and mort a l i t y.
So we are left with a real dilemma,
but it is certainly pertinent to
question if more of the same stud-
ies are likely to provide any differ-





By way of attempting to approach
this question, let us consider the
following:
Over millions of years, evolving
humankind has had to cope with
lean times and times of plenty, but
the consensus is that our forebears
survived on diets that were pre-
dominantly plant based.5-7 Indeed
from an evolutionary and epidemi-
ological point of view, it is only in
the immediate past with the 
‘westernisation’ of considerable
populations that our diets have
included increasing quantities of
While some benefits
have been demon -
strated in several of
the individual stud -
ies, nothing consis -
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animal products, and in particular
large quantities of animal fats from
animals that are increasingly fed a
non-wild and highly restricted diet.
For example, between 1967 and
1997 in both Asia and the Middle
East, per capita availability of calo-
ries derived from animal sources
more than doubled, and in
Malaysia, while total calories avail-
able increased by 24% during this
same 30-year period, calories avail-
able from fat increased by 164%.
However, not only has the intake
of animal fats increased over this
period, but there is in many west-
ernising countries, an ongoing
increase in the availability and
intake of saturated fats and of the
even more deleterious trans-fatty
acids.
Trans-fatty acids raise small dense
LDL-cholesterol levels and
markedly lower the favourable
HDL fractions,8 and increase the
risk for coronary heart disease.9
The acknowledged deleterious
effects of such lipids must be taken
into account in the overall picture,
as must the worldwide increase in




have shown and continue to show
the overall health benefits of a diet
rich in fruit and vegetables, and of
olive oil10,11 and red wine,12 with a
good intake of deep cold-sea fish.13-
15 Indeed, several such large, long-
term population studies have
demonstrated benefits not readily
achievable with any allopathic
medications.16 The US Nurses
Health Study showed an 80%
reduction in the incidence of coro-
nary events by ‘healthy lifestyle’.17
A study of a ‘Garden of Eden’ diet
(fruit, vegetables and nuts) given to
10 healthy men and women for 14
days, provided a 30% reduction in
LDL-cholesterol levels and a
much-improved LDL/HDL ratio.18
This suggests that the current
‘quick-food supermarket’ diet is a
disaster.
WHERE DOES THIS LEAVE
US?  
It seems likely that it is a basic
error to regard individual dietary
antioxidants as equivalent or even
similar to allopathic pharmacother-
apeutic agents. We have evolved
with an intake of a wide variety of
foodstuffs that provide a vast mix
of nutrients and antioxidants. Is it
not possible, perhaps even proba-
ble, that by selecting individual
antioxidants for clinical trials (and
for everyday supplementation) we
create a gross dietary imbalance
among these active radical scav-
engers?  Substance for this argu-
ment would certainly seem to
reside in the fact that individual
antioxidants — when present in
large quantities — readily become
pro-oxidant. Almost every individ-
ual antioxidant seems to have the
ability to become pro-oxidant
when taken out of context — the
context being its concentration and
its natural congeners as found in
whole foodstuffs.
The carotenoid family consists of
some 600 members; perhaps by
selecting β-carotene as a represen-
tative of this family and dosing it in
large amounts, the ‘best balance’ of
the carotenoids is grossly dis-
turbed, and then we find either no
benefits or much worse — for
example an increase in lung can-
cer.19 β-carotene in excess readily
becomes pro-oxidant.20
Similarly, vitamin E is a family of 8
members, each probably having
important roles to play, and dosing
with large quantities of any single
member may well be disadvanta-
geous; for instance, it has been
shown that high intake of α-toco-
pherol lowers the levels of γ-toco-
pherol.21 It is evident that a fine
balance exists between the levels of
the E vitamins and vitamin C,
which is important for the appro-
priate regeneration of oxidised vita-
min E back to its antioxidant form.
Studies examining the role of vita-
min E in various conditions have
provided us with highly ambiguous
information: some studies show
minor benefits, many show no ben-
efits at all,22 while some show detri-
mental effects. The HOPE study
compared ramipril with vitamin E
supplementation and found no
benefits in the vitamin E
recipients.23
A paper entitled ‘The ambivalence
of vitamin E in atherogenesis’ is at
pains to indicate that vitamin E (as
α-tocopherol) can promote peroxi-
dation if co-antioxidants are defi-
cient and it is administered in large
doses.24 In a study of patients in
Gauteng with familial hypercholes-
terolaemia, vitamin E supplemen-
tation (1 000 mg/day for 2 years)
provoked more rapid increase in
the intima-media thickness of the
carotid arteries than had been
found in control subjects.25
Then again in foodstuffs, vitamin
C is always present in company
with a host of associated antioxi-
dants chiefly as a vast array of
When we supple -
ment with large
quantities of individ -
ual antioxidants, we
would seem to be at
risk of deleteriously
disturbing the opti -
mal antioxidant bal -
ance that whole
foods would
p r o v i d e .
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flavonoids. There is some evidence that a daily
intake of vitamin C in excess of 200 mg has been
associated with an increase of atherosclerotic lesions
and regular megadoses raise blood glucose26 and can
inactivate vitamin B12.
27 Is this because vitamin C in
excess becomes pro-oxidant, and/or is it because the
balance among all the thousands of antioxidants is
detrimentally perturbed?  The paper entitled
‘Vitamin C: poison, prophylactic or panacea?’28 indi-
cates just how readily excessive vitamin C becomes
pro-oxidant, especially in the presence of ionic iron
and other metals, with a real propensity to damage
DNA.29
Consider that 30 g of dried almonds contain about
6.5 mg of total vitamin E; we would need to ingest
something like 4.3 kg of these almonds to obtain 1
000 mg vitamin E, or 62 cups of wheat germ!  From
these food sources we would get the total vitamin E
family, not just α-tocopherol, along with thousands
of other nutrients!
Thus, when we supplement with large quantities of
individual antioxidants, we would seem to be at risk
of deleteriously disturbing the optimal antioxidant
balance that whole foods would provide, probably
also inducing pro-oxidative effects, and perturbing
the finely balanced metabolic processes of relevant
cells.
However, if the non-antioxidant actions of these
antioxidants are examined, they are found to be
diverse and profound: for example, α-tocopherol has
antiplatelet and anticoagulant activity, but γ-toco-
pherol is much more active in this regard.30 The
tocotrienols have significant additional statin-like
activity with a notable ability to raise HDL-choles-
terol and lower LDL-cholesterol.31 The non-antioxi-
dant activities of these antioxidants must also receive
attention.32
WHAT ABOUT WHOLE FOOD EXTRACTS
OR CONCENTRATES?
Many so-called phytoceuticals are made available as
‘teas’, as dry powders, or as concentrated alcoholic
or aqueous extracts. It is apparent that such extracts
Antioxidants as individual
agents cannot be recommend -
ed in the primary or 
secondary prevention or 
treatment of disease
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contain many of the actives of the
original plants. Humankind has
used dried herbs of many types
down through the millennia, and
many herbs have demonstrated
health benefits. The ‘green pies’ of
Crete are largely of wild plant ori-
gin, and form a valuable compo-
nent of the diets of those Cretans
who follow the traditional diets of
former generations, and which
confer remarkably low levels of
cardiovascular disease.33,34 Whole
fruits and the juice of plants have
been shown to lower body levels of
nitrosation products  — good evi-
dence of multiple and effective car-
cinogen reduction.35
Supplementation with n-3 polyun-
saturated fatty acids to counter the
massive increase in the Western
diet of n-6 f atty acid intake, would
make a most notable impact on the
incidence of many diseases.36-39
BASELINE ASPECTS OF
ANTIOXIDANT STUDIES
When trials of individual antioxi-
dants are performed, it is most
unusual for the investigators to
establish the baseline levels of the
particular antioxidant in each
recipient or to establish their gen-
eral antioxidant status. Persons
who are antioxidant-replete may
well respond very differently com-
pared with persons who are defi-
cient; and those who are deficient
may well also be deficient in many
closely related, and not-so-closely
related, dietary essentials. This
must contribute to the ‘blurring’ of
effects of these antioxidants, and
thus to the highly equivocal overall
clinical picture regarding the bene-
fits or demerits of individual
antioxidants.
A recent study with placebo con-
trol40 is pertinent in this regard: it
examined the effects of multivita-
min-mineral and vitamin E supple-
mentation in persons 60 years of
age and older who were known to
be vitamin C and vitamin E
replete, and found no benefit from
the multivitamin-mineral supple-
mentation, but found a significant-
ly higher incidence and severity of
respiratory tract infections in the
vitamin E supplemented group.
Was the excess vitamin-E being
pro-oxidant and deleteriously
interfering with the immune
response?
CONCLUSION
We require convincing proof of
positive effects from supplementa-
tion with individual antioxidants,
and we must have proof that there
is an absence of harm with large
daily individual antioxidant intakes
before the population at large is
enticed — as it currently is — to
make use of them.41
It seems that we need to accept
that bodily levels of individual
antioxidants are just biomarkers for
the adequacy or otherwise of
dietary intake. Surely then, it is the
entire diet that must be optimised
and not just a couple of biomark-
ers?
A healthful lifestyle with no smok-
ing, adequate amounts of physical
exercise, and a diet rich in fruits,
vegetables, whole grain cereals,
dietary fibre and unsaturated fats,
and low in salt and saturated and
trans-fatty acids, has shown quite
spectacular health benefits.
However, this lifestyle is currently
quite inadequately recommended,
and is grossly overwhelmed by the
prevalent acceptance of, and pro-
paganda for, the concept that
health can come from a ‘pill’.
Antioxidants as individual agents
cannot be recommended in the
primary or secondary prevention
or treatment of disease. Only by a
good diet as part of a good
lifestyle, can this be safely and
effectively accomplished.
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IN A NUTSHELL
Individual antioxidants are widely
advocated for their presumed
health benefits.
While the theory seems convinc-
ing, major clinical studies show
no benefits and some show dele-
terious repercussions.
The true Mediterranean type diets
have been shown to confer
remarkable benefits
We give quite insufficient atten -
tion given to such overwhelming-
ly positive information.
Our emphasis should be on
actively ‘prescribing’ a good
lifestyle. 
A good lifestyle includes a daily
intake of a diet rich in fruits and
vegetables, and with a balanced
intake of omega-3 fatty acids, low
in saturated fats and trans-fatty
acid, with no smoking and with
regular physical exercise.
The benefits of such a lifestyle
can’t be mimicked by any ‘pill or
potion’.
